Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Patrick Magill"'
Autor:
Craig Underhill, John R. Mackey, Carolina Gutierrez, C. Kent Osborne, Mark V. Sellers, David L. Rimm, Rachel Schiff, Valsamo Anagnostou, Luc Dirix, Patrick Magill, Jean Robert, Patrick Neven, I. Migliaccio
Publikováno v:
Clinical Cancer Research. 17:1147-1159
Purpose: Increased growth factor signaling may contribute to tamoxifen resistance. This randomized phase II trial assessed tamoxifen plus placebo or the epidermal growth factor receptor inhibitor gefitinib in estrogen receptor (ER)–positive metasta
Autor:
Melanie Royce, Joan Kroener, Sarah S. Bacus, Elizabeth Curcio, Massimo Cristofanilli, Elsa M. Cora, Patrick Magill, Vicente Valero, Claire Watkins, Francis P. Arena, Aroop Mangalik, Ian Rabinowitz, Elizabeth Anderson
Publikováno v:
Clinical Cancer Research. 16:1904-1914
Purpose: This phase II randomized trial evaluated the efficacy and tolerability of anastrozole combined with gefitinib or anastrozole with placebo in women with hormone receptor–positive metastatic breast cancer (MBC). Experimental Design: Postmeno
Autor:
Janine Salter, G. Walsh, Patrick Magill, Anthony Skene, Mitch Dowsett, Ian E. Smith, Antonio Llombart, Jose I. Mayordomo, Simone Detre, Emma Clark
Publikováno v:
Journal of Clinical Oncology. 25:3816-3822
Purpose Increased epidermal growth factor receptor (EGFR) expression may promote breast cancer resistance to endocrine therapy. We have therefore investigated whether neoadjuvant gefitinib, an EGFR inhibitor, might overcome biologic and clinical resi
Autor:
Yi-Long Wu, Kwok Chi Lam, Patrick Magill, Yuh Min Chen, Meilin Liao, Nagahiro Saijo, James Chih-Hsin Yang, Alison Armour, Shunichi Negoro, H.-P. Kuo, Da Tong Chu, Sumitra Thongprasert, Emma Duffield, Masahiro Fukuoka
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11)
Evaluation of health-related quality-of-life (HRQoL) and symptom improvement were preplanned secondary objectives for the overall population and posthoc analyses for epidermal growth factor receptor (EGFR) mutation-positive/negative subgroups in IPAS
Autor:
Wilrike Pasman, Patrick Magill, Trinette van Vliet, Xu Jin, Shouming Zhong, Stephen Kennedy, Christine Voors, Cor Kistemaker, Hongwen Yu
Publikováno v:
Fertility and sterility. 86(3)
A proof-of-concept study to assess the safety and efficacy of a traditional Chinese medicine formula as treatment for primary dysmenorrhea showed no statistically significant benefit over placebo. However, some efficacy parameters suggested possible
Autor:
Patrick Magill, Jill Norman
Publikováno v:
Journal of the Royal Society of Medicine. 83:197-198